Breakout D Quality Risk Management

Slides:



Advertisements
Similar presentations
Project Quality Plans Gillian Sandilands Director of Quality
Advertisements

Module N° 4 – ICAO SSP framework
Session No. 4 Implementing the State’s Safety Programme Implementing Service Providers SMS
Achieve Benefit from IT Projects. Aim This presentation is prepared to support and give a general overview of the ‘How to Achieve Benefits from IT Projects’
What is GARP®? GARP® is an Acronym for Generally Accepted Recordkeeping Principles ARMA understands that records must be.
1 Implementation of Quality by Design (QbD): Status, Challenges and Next Steps Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS,
Introduction to the Supply Chain Risk Management Guide RPSGB, London 23 rd February 2010 Jill Jenkins - Pharmaceutical Quality Group.
Breakout C Pharmaceutical Quality System (PQS)
Integrating CMC Review & Inspection Industry Recommendations Joe Anisko April 24, 2003.
The Pharmaceutical Industry and ICH Q9
GCP compliance for GenISIS  This presentation is intended for clinical staff involved in recruiting patients to the GenISIS (Genetics of Influenza Susceptibility.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
The Australian/New Zealand Standard on Risk Management
Please read this before using presentation This presentation is based on content presented at the Industry Forum on Reducing.
What Is Quality by Design?. Quality by Design: QbD Defined Prospectively examining the objectives of a trial and defining factors critical to meeting.
What SMS means for an Operator’s relationship with the CAA
Tony Gould Quality Risk Management. 2 | PQ Workshop, Abu Dhabi | October 2010 Introduction Risk management is not new – we do it informally all the time.
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
Quality System Model ICH Q10
Frequently Asked Questions (FAQ) prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
ICH Q9: Quality Risk Management
Quality Risk Management ICH Q9 Annex I: Methods & Tools
Manufacturing Implementation and the Pharmaceutical Quality System
Opportunities & Implications for Turkish Organisations & Projects
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
ONDQA Perspective on Post Approval Changes Eric P. Duffy, PhD Director, Division of Post-Market Evaluation, ONDQA, CDER, FDA Public Meeting: Supplements.
Session No. 4 Implementing Service Providers SMS Implementing the State’s Safety Programme SMS Senior Management Workshop Rome, 21 May 2007.
Internal Auditing and Outsourcing
Executive summary prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY RISK MANAGEMENT.
Effectively applying ISO9001:2000 clauses 5 and 8
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
Introduction to Quality, Cost & Delivery
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
Organizational Gaps in Reaching the “Desired State” Helen Winkle.
Postgraduate Educational Course in radiation protection and the Safety of Radiation sources PGEC Part IV The International System of Radiation Protection.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
World Health Organization
Annex II: Potential Applications prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9.
Demystifying the Business Analysis Body of Knowledge Central Iowa IIBA Chapter December 7, 2005.
Module N° 8 – SSP implementation plan. SSP – A structured approach Module 2 Basic safety management concepts Module 2 Basic safety management concepts.
Certification and Accreditation CS Phase-1: Definition Atif Sultanuddin Raja Chawat Raja Chawat.
QUALITY RISK MANAGEMENT RASHID MAHMOOD MSc. Analytical Chemistry MS in Total Quality Management Senior Manager Quality Assurance Nabiqasim Group of Industries.
Annex I: Methods & Tools prepared by some members of the ICH Q9 EWG for example only; not an official policy/guidance July 2006, slide 1 ICH Q9 QUALITY.
Statistics New Zealand’s End-to-End Metadata Life-Cycle ”Creating a New Business Model for a National Statistical Office if the 21 st Century” Gary Dunnet.
Paul Hardiman and Rob Brown SMMT IF Planning and organising an audit.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
PhRMA Perspective on FDA Final Report FDA Advisory Committee on Pharmaceutical Sciences October 20, 2004 G.P. Migliaccio, Pfizer Inc.
Molecule-to-Market-Place Quality
1 EMS Fundamentals An Introduction to the EMS Process Roadmap AASHTO EMS Workshop.
Part 11 Public Meeting PEERS Questions & Responses The opinions expressed here belong to PEERS members and not the corporate entities with which they are.
General Aspects of Quality assessment of multisource interchangeable medicines Rutendo Kuwana Technical Officer, WHO, Geneva Training workshop: Assessment.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Management Systems Part I.
Kathy Corbiere Service Delivery and Performance Commission
Ensuring the Safety of Future Developments
ICH Quality Topics Update
CDER / Office of Compliance ACPS October 5, 2006 Joseph C. Famulare Acting Deputy Director Office of Compliance CDER / FDA.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
SOLGM Wanaka Retreat Health and Safety at Work Act 2015 Ready? 4 February 2016 Samantha Turner Partner DDI: Mob:
Organizations of all types and sizes face a range of risks that can affect the achievement of their objectives. Organization's activities Strategic initiatives.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Implementation of ICH Q8, Q9, Q10.
GCP (GOOD CLINICAL PRACTISE)
Quality Risk Management
Quality System.
HSE Case: Risk Based Approach.
ICH Q9: Quality Risk Management
ICH Q9: Quality Risk Management
Implementation of Quality by Design (QbD): Status, Challenges and Next Steps Moheb M. Nasr, Ph.D. Office of New Drug Quality Assessment (ONDQA), OPS, CDER.
Quality Risk Management ICH Q9 Frequently Asked Questions (FAQ)
Pharmaceutical Quality Group David Abraham
Presentation transcript:

Breakout D Quality Risk Management

Disclaimer The information within this presentation is based on the ICH Q-IWG members expertise and experience, and represents the views of the ICH Q-IWG members for the purposes of a training workshop. © ICH, November 2010

Introduction Structure of this session Discussion of key messages on QRM Examples from the Case Study Wrap up Feedback on barriers to implementation Feedback on issues where further clarification is required Breakout report © ICH, November 2010

Goals of this Breakout Facilitate understanding of the QRManagement process Using example of the case study describe the QRM process Ability to use the QRM process cycle in your organisation i.e. Development, Assessment, Manufacturing, Inspections / Audit Facilitate understanding of the linkage between QRM and knowledge management Feedback to Q-IWG © ICH, November 2010

Key Message - Why use QRM? Use of QRM can improve the decision making processes from development, technical transfer, manufacturing, post approval changes and throughout the entire product life cycle © ICH, November 2010

Key Messages Quality Risk Management is the full process Quality Risk Assessment, Control, Review etc. represent only individual steps ICH Q9 © ICH, November 2010

Key Messages QRM is an iterative process and not a one off activity Utilisation of QRM activities should lead to a greater assurance of quality through risk control Facilitate the awareness of risks Risk does not go away Risk can be predicted, prevented and controlled QRM processes should Focus on what is important to establish the manufacturing process and controls and maintain them over the life cycle Be integrated in Pharmaceutical Quality System elements © ICH, November 2010

Key Messages QRM used by company can provide regulators with greater assurance of a company’s product and process understanding and the ability to assure quality of manufactured products QRM should be used by regulators (both assessors and inspectors) to guide regulatory activities independent of the industry utilisation of QRM © ICH, November 2010

Key Messages Regulators should use QRM methods appropriately to reach rational and justified regulatory decisions e.g. Risk based regulatory decisions (suspected quality defects etc.) Assessment of regulatory filing Planning and conducting of inspections Prioritisation of inspection findings © ICH, November 2010

QRM in the Product Life Cycle 1/4 3/4 approx. life cycle time Knowledge management Technical Transfer Patient needs Manu- facturing Process design Product design Control Strategy Commercial Manufacturing Research and clinical studies Business needs PAI Inspections GMP Inspections Quality Target Product Profile (QTPP) Critical Quality Attribute (CQA) Critical Process Parameters (CPP) Technical regulatory Filing & Review Performance Review & Change Control Opportunities to apply Quality Risk Managements Process understanding © ICH, November 2010

Key Messages Two primary principles of QRM are The evaluation of the risk to quality should be based on scientific knowledge and ultimately link to the protection of the patient The level of effort, formality and documentation of the quality risk management process should be commensurate with the level of risk ICH Q9 © ICH, November 2010

Key Messages Reduce subjectivity of implementing QRM by making sure the right people are at the table (e.g. multi-discipline, include respective stakeholders, as applicable) Use QRM methods appropriately and present the conclusions and justifications clearly Be clear and consistent in wording / terms used based on internationally agreed definitions Transparency on the logic of the methodology and the decision making QRM can not be used to justify failure Use QRM proactively for increasing the knowledge of your product and processes © ICH, November 2010

Linkage between QRM and Knowledge Management Definition on Knowledge Management Systematic approach to acquiring, analysing, storing, and disseminating information related to products, manufacturing processes and components (ICH Q10) © ICH, November 2010

Linkage between QRM and Knowledge Management Risk assessment as part of QRM in relation to knowledge management can be linked to Identifying data to be collected (risk identification) Analysing raw data (risk analysis) Evaluating the results from measurement will lead to information (risk evaluation) New information should be assessed and the risk control decision captured (risk review and risk control) Knowledge management facilitates risk communication among stakeholders © ICH, November 2010

Linkage between QRM and Knowledge Management In conjunction with QRM, Knowledge Management as systematic activity can facilitate e.g. Usage of prior knowledge (including from other similar products) Development, implementation and maintenance of the Design Space and Control Strategy Technology transfer Continual improvement of the product and manufacturing processes across its life cycle Continual improvement of Quality System elements (including documentation) © ICH, November 2010

Exercise Which QRM step the following examples belongs to? You will see examples from the case study Please discuss and suggest which steps of the QRM process those belong to © ICH, November 2010

Which QRM step this example belongs to? © ICH, November 2010

Which QRM step these examples belongs to? © ICH, November 2010

On which step of the QRM process you do not find an example in the case study? © ICH, November 2010

Which QRM step this example belongs to? © ICH, November 2010

Which QRM step these examples belongs to? © ICH, November 2010

Which QRM step this example belongs to? © ICH, November 2010

Which QRM step these examples belongs to? © ICH, November 2010

Topics to Discuss 1. What is the benefit using QRM in development, assessment, manufacturing and/or inspection? 2. What are the expectations of the level of training and understanding for regulators and industry in order to use the methods appropriately? 3. How to link quality risk management to knowledge management? 4. What level of detail on QRM need to be included in a submission (general / case by case)? © ICH, November 2010

Topics to Discuss A. How can industry demonstrate the robustness of a QRM process? Aa) In regulatory filing? Ab) In manufacturing operations? B. How does an assessor independently evaluate the company’s risk management conclusion? C. How could inspectors use QRM principles to align risk based decisions? © ICH, November 2010

Feedback to ICH Q-IWG Are we clear with the key messages? Yes / No Are there practical concerns on implementation? (e.g. on harmonisation among regions needes, by region/local issue) Where is more clarification required for practical harmonised implementation? © ICH, November 2010

Did we meet the goals? Facilitate understanding of the QRManagement process Using example of the case study describe the QRM process Ability to use the QRM process cycle in your organisation i.e. Development, Assessment, Manufacturing, Inspections/Audit Facilitate understanding of the linkage between QRM and knowledge management Feedback to Q-IWG © ICH, November 2010

Acknowledgement This presentation has been developed by members of the ICH Quality Implementation Working Group (Q-IWG) Jean-Louis Robert (rapporteur) Diana Amador-Toro Robert G. Baum Nicholas Cappuccino David Cockburn Georges France Richard L. Friedman Nigel Hamilton Hirotada Nagai Yukio Hiyama Fusashi Ishikawa Takao Kiyohara Urs Kopp Akira Kusai Yoshihiro Matsuda Motoaki Mitsuki Elaine Morefield Jacques Morénas Masatoshi Morisue Markus-Peter Müller Tamiji Nakanishi Moheb Nasr Kazuhiro Okochi Anthony Ridgway Rachael Roehrig Stephan Rönninger Swroop Sahota Hideki Sasaki Tetsuhito Takarada Shigeki Tamura Krishnan Tirunellai Mats Welin Jean M. Wyvratt A J van Zyl © ICH, November 2010

Breakout D - Back up Quality Risk Management Suggested answers slide 17-23

Which QRM step this example belongs to? © ICH, November 2010 Risk reduction as part of risk control

Which QRM step these examples belongs to? © ICH, November 2010 Risk identification as part of risk assessment

On which step of the QRM process you do not find an example in the case study? Risk review It should be in PQS elements and it’s review No risk review may lead to reactive Change Management topics © ICH, November 2010

Which QRM step this example belongs to? © ICH, November 2010 Risk analysis as part of risk assessment

Which QRM step these examples belongs to? Risk communication External: submission Internal: technical transfer process © ICH, November 2010

Which QRM step this example belongs to? © ICH, November 2010 Risk acceptance as part of risk control

Which QRM step these examples belongs to? © ICH, November 2010 Risk evaluation as part of risk assessment